14 hrs ago
Is Abbott Laboratories Better Than Johnson & Johnson For Your Dividend Portfolio?
Johnson & Johnson has the lowest volatility of any business with 25+ years of dividend payments without a reduction.
Trending on the Topix Network
Thu Jul 10, 2014
The Motley Fool
Is This Huge Market Slowing Down?
Waiting for a recovery in the orthopedic market isn't exactly waiting for Godot, but it has been frustrating all the same.
Earnings Preview: Johnson & Johnson Q2 2014
Johnson & Johnson is slated to report 2Q 2014 earnings before the opening bell on Tuesday, July 15th.
The Washington Post
Spinversions Make Giants Candidates to Escape U.S. Tax: Real M&A
American conglomerates that want a piece of the tax-inversion deal bonanza may start turning to a new tactic.
Philadelphia Gay News
N.J.-based corp. marks third year of LGBT initiative
Five years ago, Johnson & Johnson started hosting Gay 101 "lunch and learns" to find out more about the LGBT community as a consumer group.
Wed Jul 09, 2014
Has Johnson & Johnson Finally Met Its Match?
In the latest instalment of our Head-To-Head series, we pitch two companies from the health care sector, Johnson & Johnson and Covidien, against one another.
White House pulls plug on controversial Patent Office nominee after tech sector backlash
The Obama Administration has backed away from an unpopular plan to name a Johnson & Johnson executive and patent reform opponent as head of the US Patent Office.
Tue Jul 08, 2014
Energizer Holdings to shut Montreal factory; 430 jobs gone
Just nine months after buying the east-end Johnson & Johnson factory, Energizer Holdings announced Tuesday it will shut down the facility beginning next summer.
Oxford BioTherapeutics Appoints As Head Of Clinical Development
Oxford BioTherapeutics, an international biotechnology company focused on the development of innovative antibody-drug conjugates for the treatment of cancer, announced today the appointment of Eugen Leo, MD, PhD, MBA, as Head of Clinical Development.
Why This Johnson & Johnson Exec Shouldn't Be the Next U.S. Patent Office Director
Philip Johnson is Chief Intellectual Property Counsel of Johnson & Johnson, one of the largest pharmaceutical companies in the world.
Sun Jul 06, 2014
Chris Martin Is Giving Gwyneth A Meaty Middle Finger
Chris Martin had to give up a lot during his marriage to Gwyneth Paltrow . His dignity, warmth and affection, the ability to use normal products like Johnson&Johnson soap and tap water.
Fri Jul 04, 2014
Johnson & Johnson: Valuation Not Attractive Despite Impressive Strategic Alliance
Despite this Johnson & Johnson is expected to grow at a CAGR of ~10% for the next five years, its valuation isn't attractive enough.
Thu Jul 03, 2014
Medford Mail Tribune
Hip-replacement lawsuits continue to increase locally
ACentral Point man who had heavy metals enter his bloodstream from his hip-replacement device is joining nearly 100 others locally who have filed lawsuits against the device manufacturer.
Wed Jul 02, 2014
Artificial hip maker must pony up $4M to Oregon for 'alarming failure rate of failure'
The Oregon Department of Justice reached a $4 million settlement with a subsidiary of Johnson & Johnson over allegations of deceptive marketing practices surrounding artificial hip devices.
Report: DePuy Synthes eliminating 400 positions
Johnson & Johnson is eliminating about 400 jobs at its DePuy Synthes medical device subsidiary, according to a Wall Street Journal report .
Outlook For July 2014
Summer is finally here! The stock market continues to hover around the all-time highs relentlessly.
Mon Jun 30, 2014
Fisher-Price Targets Millennial Moms for the Royal Baby's Birthday
The idea of brands becoming publishers has been around for a couple years , as businesses have en masse created social media pages and content blogs to promote their wares.
Sun Jun 29, 2014
FIPB to take up 31 foreign investment proposals on July 4
Finance Ministry will take a call on 31 proposals of foreign direct investment, including that of Johnson & Johnson and Monsanto Holdings, next week.
Thu Jun 26, 2014
Corporate Action Network and Ohio Women Request Attorney General...
Citing their personal health problems and costs incurred, Ohio women who have been seriously injured by pelvic mesh implants requested that Ohio Attorney General Mike DeWine investigate the pelvic mesh industry for its dangerous implants.
DePuy cuts jobs in Warsaw
DePuy Synthes Cos. has eliminated an undisclosed number of jobs, affecting a portion of the company's Warsaw workforce, an official confirmed Wednesday.